This SEUD symposium review article reports on how benign smooth muscle uterine tumours known as uterine fibroids can be extremely debilitating for many women, leading to heavy menstrual bleeding, pain, and a substantial reduction in quality of life. The recent availability of gonadotropin-releasing hormone (GnRH) antagonists such as linzagolix may offer effective treatment options for women affected by this debilitating condition.
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Latest articles
All articles


